| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.2M | -29.9% |
| R&D Expense | $13.1M | +2.4% |
| SG&A Expense | $61.5M | +21.7% |
| Operating Income | -$50.6M | -23.6% |
| Interest Expense | $8.1M | +79.1% |
| Income Tax | $0 | — |
| Net Income | -$65.4M | -51.6% |
| EPS (Basic) | -$1.55 | +1.9% |
| EPS (Diluted) | -$1.55 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.1M | +31.7% |
| Accounts Receivable | $5.1M | +38.5% |
| Current Assets | $53.3M | +22.3% |
| Total Assets | $92.9M | +22.1% |
| Current Liabilities | $22.8M | -21.1% |
| Long-term Debt | $30.1M | +199.0% |
| Total Liabilities | $72.3M | +28.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.0M | -59.3% |
| Capital Expenditures | $3.3M | +47.2% |
| Investing Cash Flow | -$3.5M | -38.8% |
| Financing Cash Flow | $58.9M | +4565.8% |
| Free Cash Flow | -$48.3M | -58.4% |
| +1.9% |
| Stockholders' Equity |
| $20.6M |
| +4.5% |